ENST00000396365.7:c.614G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000396365.7(LILRA6):​c.614G>A​(p.Arg205Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.291 in 1,255,248 control chromosomes in the GnomAD database, including 46,194 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.30 ( 4176 hom., cov: 23)
Exomes 𝑓: 0.29 ( 42018 hom. )

Consequence

LILRA6
ENST00000396365.7 missense

Scores

16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.628

Publications

15 publications found
Variant links:
Genes affected
LILRA6 (HGNC:15495): (leukocyte immunoglobulin like receptor A6) Predicted to enable inhibitory MHC class I receptor activity. Predicted to be involved in cytokine-mediated signaling pathway. Predicted to be integral component of membrane. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
RPS9 (HGNC:10442): (ribosomal protein S9) Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 40S subunit. The protein belongs to the S4P family of ribosomal proteins. It is located in the cytoplasm. Variable expression of this gene in colorectal cancers compared to adjacent normal tissues has been observed, although no correlation between the level of expression and the severity of the disease has been found. As is typical for genes encoding ribosomal proteins, multiple processed pseudogenes derived from this gene are dispersed through the genome. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002255261).
BP6
Variant 19-54241620-C-T is Benign according to our data. Variant chr19-54241620-C-T is described in ClinVar as Benign. ClinVar VariationId is 403040.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.383 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LILRA6NM_024318.5 linkc.614G>A p.Arg205Gln missense_variant Exon 4 of 8 NP_077294.3 U5XH19
LILRA6NR_104098.2 linkn.611+42G>A intron_variant Intron 4 of 9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LILRA6ENST00000396365.7 linkc.614G>A p.Arg205Gln missense_variant Exon 4 of 8 1 ENSP00000379651.2 Q6PI73

Frequencies

GnomAD3 genomes
AF:
0.305
AC:
35130
AN:
115262
Hom.:
4175
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.326
Gnomad AMI
AF:
0.282
Gnomad AMR
AF:
0.316
Gnomad ASJ
AF:
0.217
Gnomad EAS
AF:
0.355
Gnomad SAS
AF:
0.361
Gnomad FIN
AF:
0.276
Gnomad MID
AF:
0.250
Gnomad NFE
AF:
0.291
Gnomad OTH
AF:
0.310
GnomAD2 exomes
AF:
0.0533
AC:
10421
AN:
195684
AF XY:
0.0508
show subpopulations
Gnomad AFR exome
AF:
0.140
Gnomad AMR exome
AF:
0.0446
Gnomad ASJ exome
AF:
0.0259
Gnomad EAS exome
AF:
0.107
Gnomad FIN exome
AF:
0.0607
Gnomad NFE exome
AF:
0.0380
Gnomad OTH exome
AF:
0.0564
GnomAD4 exome
AF:
0.290
AC:
330699
AN:
1139888
Hom.:
42018
Cov.:
38
AF XY:
0.295
AC XY:
168075
AN XY:
569790
show subpopulations
African (AFR)
AF:
0.315
AC:
8255
AN:
26168
American (AMR)
AF:
0.285
AC:
11106
AN:
39030
Ashkenazi Jewish (ASJ)
AF:
0.246
AC:
5090
AN:
20688
East Asian (EAS)
AF:
0.363
AC:
12796
AN:
35272
South Asian (SAS)
AF:
0.387
AC:
25653
AN:
66220
European-Finnish (FIN)
AF:
0.346
AC:
16209
AN:
46880
Middle Eastern (MID)
AF:
0.313
AC:
1337
AN:
4278
European-Non Finnish (NFE)
AF:
0.276
AC:
235569
AN:
853392
Other (OTH)
AF:
0.306
AC:
14684
AN:
47960
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.400
Heterozygous variant carriers
0
10730
21460
32189
42919
53649
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7338
14676
22014
29352
36690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.305
AC:
35172
AN:
115360
Hom.:
4176
Cov.:
23
AF XY:
0.304
AC XY:
16927
AN XY:
55636
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.326
AC:
10428
AN:
32010
American (AMR)
AF:
0.317
AC:
3683
AN:
11636
Ashkenazi Jewish (ASJ)
AF:
0.217
AC:
542
AN:
2502
East Asian (EAS)
AF:
0.355
AC:
1493
AN:
4204
South Asian (SAS)
AF:
0.360
AC:
1062
AN:
2948
European-Finnish (FIN)
AF:
0.276
AC:
2118
AN:
7664
Middle Eastern (MID)
AF:
0.242
AC:
47
AN:
194
European-Non Finnish (NFE)
AF:
0.291
AC:
15108
AN:
51920
Other (OTH)
AF:
0.313
AC:
487
AN:
1558
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.378
Heterozygous variant carriers
0
1011
2022
3032
4043
5054
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
358
716
1074
1432
1790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.202
Hom.:
577
ExAC
AF:
0.0352
AC:
4094

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.83
T
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.25
DANN
Benign
0.71
DEOGEN2
Benign
0.0021
.;T
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.00019
N
LIST_S2
Benign
0.16
T;T
MetaRNN
Benign
0.0023
T;T
MetaSVM
Benign
-0.95
T
PhyloP100
-0.63
PROVEAN
Benign
1.4
N;N
REVEL
Benign
0.020
Sift
Benign
0.85
T;T
Sift4G
Benign
0.60
T;T
Vest4
0.029
MPC
1.1
ClinPred
0.000020
T
GERP RS
2.4
gMVP
0.095
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61734495; hg19: chr19-54745496; COSMIC: COSV54432752; COSMIC: COSV54432752; API